Stock ASTRAZEN ASTRAZENECA PHARMA INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Market Closed - Bombay S.E.
Other stock markets
 11:00:53 25/06/2024 BST 		5-day change 1st Jan Change
6,320 INR +0.01% Intraday chart for AstraZeneca Pharma India Limited -2.14% +14.49%
06-21 AstraZeneca Pharma Fails to Find Buyer for Manufacturing Site in Bangalore, India MT
06-01 Astrazeneca Pharma India Limited Appoints Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy, Effective June 17, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca Pharma Fails to Find Buyer for Manufacturing Site in Bangalore, India
Astrazeneca Pharma India Limited Appoints Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy, Effective June 17, 2024
Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4
AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director
Astrazeneca Pharma India Limited Recommends Dividend for the Financial Year 2023-24
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India
Astrazeneca Pharma India Limited Announces Board Changes
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
AstraZeneca Pharma India Limited Announces Board Changes
AstraZeneca Pharma India Limited Announces Directorate Appointments
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024
India's Nifty set for muted open after steep drop
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASTRAZEN Stock
  4. News AstraZeneca Pharma India Limited
  5. Other languages